Transcutaneous Vagal Nerve Stimulation in Veterans With Posttraumatic Stress Disorder
VNS in PTSD
2 other identifiers
interventional
80
1 country
1
Brief Summary
This study effects the effects of transcutaneous cervical vagal nerve stimulation (tcVNS) or a sham control on brain, physiology, and PTSD symptoms in Veterans with posttraumatic stress disorder (PTSD). Veterans undergo brain imaging and physiological measures in conjunction with traumatic scripts before and after three months of twice daily treatment with tcVNS or sham stimulation at home.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2022
CompletedFirst Posted
Study publicly available on registry
August 26, 2022
CompletedStudy Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 10, 2027
March 3, 2026
February 1, 2026
4.8 years
August 15, 2022
February 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in PTSD symptoms
Change in PTSD symptoms measured with the Clinician Administered PTSD Scale (CAPS) and PTSD Checklist (PCL) in tcVNS versus sham conditions
Baseline to three months
Brain Activation
Change in brain activation in insula measured with PET in response to trauma scripts with VNS compared to sham
Baseline
Secondary Outcomes (2)
Sympathetic function
Baseline
Interleukin-6
Baseline
Study Arms (2)
tcVNS
EXPERIMENTALStimulation twice daily with transcutaneous Vagal Nerve Stimulation (tcVNS)
Sham
ACTIVE COMPARATORStimulation with sham
Interventions
Eligibility Criteria
You may qualify if:
- Veterans between the ages of 18 and 75 will be included with a diagnosis of PTSD based on DSM-5 criteria
You may not qualify if:
- Subjects will be excluded with:
- a history of mild traumatic brain injury (mTBI) based on VA Criteria
- moderate or greater TBI
- positive pregnancy test
- meningitis or other neurological disorder
- alcohol or substance abuse use disorder based on DSM-5 criteria within the past 12 months
- current or lifetime history of schizophrenia, schizoaffective disorder, bipolar I disorder, anorexia nervosa or bulimia, based on DSM-5
- active suicidal ideation with a plan
- a history of serious medical or neurological illness, such as cardiovascular, gastrointestinal, hepatic, renal, neurologic or other systemic illness that would preclude participation based on clinical judgment of the PI
- active opiate or benzodiazepine treatment
- history of structural abnormality on brain MRI or CT if one has been performed in the past
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, 30033-4004, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Doug J Bremner, MD
Atlanta VA Medical and Rehab Center, Decatur, GA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Sham stimulation comparison
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2022
First Posted
August 26, 2022
Study Start
October 1, 2022
Primary Completion (Estimated)
July 8, 2027
Study Completion (Estimated)
November 10, 2027
Last Updated
March 3, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Three months after study completion
- Access Criteria
- Three months after study completion for twelve months
De identified data will be made available three months after study completion